Dermatophytosis is generally defined as an
infection of the hair, nails, or glabrous skin. These
infections are caused by the keratinophilic fungi Trichophyton spp., Microsporum spp., and Epidermophyton, which have been recovered from both symptomatic and asymptomatic individuals. Although
dermatophytosis is generally not a life-threatening condition, these types of
infections are among the most common
infections worldwide, and their incidence has continued to increase consistently in recent years. Area covered: This article provides an overview of the general characteristics of dermatophytes, including their taxonomy and epidemiology, as well as the different clinical forms and laboratory diagnostics of
dermatophytosis. We further classify the topical and systemic antifungal compounds currently used to treat dermatophyte
infections. Expert commentary: Antifungal
therapy is a central component of patient management for
dermatophytosis, and depending on the strategy chosen, topical and/or systemic drugs can be used. However, for effective treatment, it is important to correctly determine the causal agents at the species level, which will enable administration of suitable
therapeutics and initiation of appropriate management strategies.